Diagnostics company Tepnel Life Sciences PLC (TED.LN) said Friday it agreed a GBP92.8 million takeover by U.S. peer Gen-Probe Inc. (GPRO).

Gen-Probe is offering Tepnel shareholders 27.1 pence in cash per share, more than double Tepnel's share price on Jan. 21, when it said it received an approach.

The acquisition of Tepnel will allow Gen-Probe to expand into tests for monitoring transplant recipients, the firm said.

Company Web site: www.tepnel.com

-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com

Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary. You can use this link on the day this article is published and the following day.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Ted Baker Charts.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Ted Baker Charts.